Published in Medical Letter on the CDC and FDA, February 18th, 2007
With more than 25 years of experience, Tuttle is widely regarded as an innovative, pioneering cell and tissue culture biologist, with extensive biopharmaceutical experience in cGMP pilot to commercial scale GMP culture, including three FDA approved human therapeutics and seven in clinical trials.
"In addition to his industry-wide experience, Dr. Tuttle's unique blend of scientific know-how and commercial scale-up expertise in cell-cultures and vaccines are very helpful for us," states Frank Menzler, president and CEO of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA